{"id":"https://openalex.org/W2604317643","doi":"https://doi.org/10.2147/dmso.s130834","title":"Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research","display_name":"Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research","publication_year":2017,"publication_date":"2017-04-01","ids":{"openalex":"https://openalex.org/W2604317643","doi":"https://doi.org/10.2147/dmso.s130834","mag":"2604317643","pmid":"https://pubmed.ncbi.nlm.nih.gov/28435305","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5389657"},"language":"en","primary_location":{"id":"doi:10.2147/dmso.s130834","doi":"https://doi.org/10.2147/dmso.s130834","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s130834","pdf_url":"https://www.dovepress.com/getfile.php?fileID=35838","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=35838","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056499278","display_name":"PHILIP A. LEVIN","orcid":"https://orcid.org/0000-0002-2410-1223","observed_orcids":["https://orcid.org/0000-0002-2410-1223"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip A Levin","raw_affiliation_strings":["Bay West Endocrinology Associates, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bay West Endocrinology Associates, Baltimore, MD","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112251630","display_name":"Hiep P. Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hiep Nguyen","raw_affiliation_strings":["Health Economics and Outcomes Research, AstraZeneca, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes Research, AstraZeneca, Wilmington, DE","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027701342","display_name":"Eric T Wittbrodt","orcid":"https://orcid.org/0000-0002-4060-7638","observed_orcids":["https://orcid.org/0000-0002-4060-7638"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Wittbrodt","raw_affiliation_strings":["Health Economics and Outcomes Research, AstraZeneca, Wilmington, DE"],"raw_orcid":"https://orcid.org/0000-0002-4060-7638","affiliations":[{"raw_affiliation_string":"Health Economics and Outcomes Research, AstraZeneca, Wilmington, DE","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100615887","display_name":"Seoyoung C. Kim","orcid":"https://orcid.org/0000-0002-2517-3579","observed_orcids":["https://orcid.org/0000-0002-2517-3579"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Seoyoung C. Kim","raw_affiliation_strings":["Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5100615887"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":2.0597,"has_fulltext":true,"cited_by_count":107,"citation_normalized_percentile":{"value":0.89872009,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"Volume 10","issue":null,"first_page":"123","last_page":"139"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9909999966621399},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.996999979019165},{"id":"https://openalex.org/keywords/comparative-effectiveness","display_name":"comparative effectiveness","score":0.7730000019073486},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8479999899864197},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9309999942779541},{"id":"https://openalex.org/keywords/insulin-therapy","display_name":"insulin therapy","score":0.7490000128746033},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.953000009059906},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.996999979019165},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/weight-loss","display_name":"weight loss","score":0.7480000257492065},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9240000247955322},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.6819999814033508},{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.824999988079071},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.9940000176429749},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/lixisenatide","display_name":"lixisenatide","score":0.9940000176429749},{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":1.0}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7252517938613892},{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.7184028625488281},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.5677013993263245},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5609613656997681},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.5556080937385559},{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.5318704843521118},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.5254458785057068},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4510211646556854},{"id":"https://openalex.org/C2777538456","wikidata":"https://www.wikidata.org/wiki/Q311213","display_name":"Glycated hemoglobin","level":4,"score":0.4306446313858032},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32767000794410706},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3071459233760834},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.22737836837768555},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13514018058776855}],"mesh":[],"locations_count":7,"locations":[{"id":"doi:10.2147/dmso.s130834","doi":"https://doi.org/10.2147/dmso.s130834","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s130834","pdf_url":"https://www.dovepress.com/getfile.php?fileID=35838","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4246955","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5389657","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5389657","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5389657","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Metab Syndr Obes","raw_type":"Text"},{"id":"pmid:28435305","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28435305","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, metabolic syndrome and obesity : targets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:dash.harvard.edu:1/32630703","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:32630703","pdf_url":null,"source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:6280559cff2643bda0e3000148b48e08","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/6280559cff2643bda0e3000148b48e08","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity, Vol Volume 10, Pp 123-139 (2017)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/32215","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/glucagon-like-peptide-1-receptor-agonists-a-systematic-review-of-compa-peer-reviewed-article-DMSO","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"}],"best_oa_location":{"id":"doi:10.2147/dmso.s130834","doi":"https://doi.org/10.2147/dmso.s130834","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s130834","pdf_url":"https://www.dovepress.com/getfile.php?fileID=35838","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2604317643.pdf","grobid_xml":"https://content.openalex.org/works/W2604317643.grobid-xml"},"referenced_works_count":78,"referenced_works":["https://openalex.org/W906438903","https://openalex.org/W1480729244","https://openalex.org/W1483095253","https://openalex.org/W1559082056","https://openalex.org/W1606810773","https://openalex.org/W1883583237","https://openalex.org/W1966379378","https://openalex.org/W1969151129","https://openalex.org/W1976287166","https://openalex.org/W1979422476","https://openalex.org/W1981662391","https://openalex.org/W1987538170","https://openalex.org/W1989713397","https://openalex.org/W1990162248","https://openalex.org/W1992055007","https://openalex.org/W1992061662","https://openalex.org/W1998281835","https://openalex.org/W2012425163","https://openalex.org/W2021163959","https://openalex.org/W2027276740","https://openalex.org/W2028092672","https://openalex.org/W2028272916","https://openalex.org/W2030546890","https://openalex.org/W2036532013","https://openalex.org/W2041064480","https://openalex.org/W2042251368","https://openalex.org/W2051493851","https://openalex.org/W2054931962","https://openalex.org/W2061691264","https://openalex.org/W2061883499","https://openalex.org/W2067533175","https://openalex.org/W2069471499","https://openalex.org/W2069665789","https://openalex.org/W2071835038","https://openalex.org/W2072691447","https://openalex.org/W2073547913","https://openalex.org/W2074177255","https://openalex.org/W2077969859","https://openalex.org/W2078090288","https://openalex.org/W2078839892","https://openalex.org/W2087188090","https://openalex.org/W2090054860","https://openalex.org/W2091000858","https://openalex.org/W2098459806","https://openalex.org/W2099352903","https://openalex.org/W2099903872","https://openalex.org/W2102211240","https://openalex.org/W2103364479","https://openalex.org/W2105926302","https://openalex.org/W2106758571","https://openalex.org/W2107949845","https://openalex.org/W2109451951","https://openalex.org/W2113367996","https://openalex.org/W2124977666","https://openalex.org/W2129377335","https://openalex.org/W2130478319","https://openalex.org/W2136546775","https://openalex.org/W2137352234","https://openalex.org/W2138290933","https://openalex.org/W2139485303","https://openalex.org/W2142400535","https://openalex.org/W2144559080","https://openalex.org/W2146466098","https://openalex.org/W2148162269","https://openalex.org/W2158778171","https://openalex.org/W2160088494","https://openalex.org/W2165556241","https://openalex.org/W2169199370","https://openalex.org/W2171136089","https://openalex.org/W2171783842","https://openalex.org/W2200208573","https://openalex.org/W2282578582","https://openalex.org/W2282876332","https://openalex.org/W2307586345","https://openalex.org/W2425644022","https://openalex.org/W2519510391","https://openalex.org/W2574032118","https://openalex.org/W4242364069"],"related_works":["https://openalex.org/W2563047690","https://openalex.org/W3134100899","https://openalex.org/W1753769072","https://openalex.org/W2097771449","https://openalex.org/W2123041020","https://openalex.org/W4381057435","https://openalex.org/W2019660534","https://openalex.org/W2141132900","https://openalex.org/W2158530272","https://openalex.org/W2152969995"],"abstract_inverted_index":{"BACKGROUND:":[0],"Glucagon-like":[1],"peptide-1":[2],"receptor":[3],"agonists":[4],"(GLP-1RAs)":[5],"act":[6],"by":[7],"increasing":[8,18],"insulin":[9,104,171,188,197],"secretion,":[10,13],"decreasing":[11],"glucagon":[12],"slowing":[14],"gastric":[15],"emptying,":[16],"and":[17,46,85,99,135,187,189,205],"satiety.":[19],"OBJECTIVE:":[20],"Published":[21],"evidence":[22],"directly":[23],"comparing":[24,52],"GLP-1RAs":[25,53,89,140,162,173,200,240],"with":[26,54,62,103,153,161,170,192,215,218],"other":[27,55],"approved":[28,88],"treatments":[29],"for":[30,75,248],"type":[31],"2":[32],"diabetes":[33],"(T2D)":[34],"was":[35,42],"systematically":[36],"reviewed.":[37],"METHODS:":[38],"A":[39],"literature":[40],"search":[41],"performed":[43],"using":[44],"MEDLINE":[45],"Embase":[47],"databases":[48],"to":[49,164,229],"identify":[50],"papers":[51,68],"classes":[56],"of":[57,87,245],"glucose-lowering":[58,185,220,246],"therapy":[59,146],"in":[60,147,151,156,178,213],"patients":[61,152,214],"T2D.":[63,154,249],"RESULTS:":[64],"Of":[65],"the":[66,72],"1303":[67],"identified,":[69],"57":[70],"met":[71],"prespecified":[73],"criteria":[74],"a":[76,144],"high-quality":[77],"clinical":[78],"trial":[79],"or":[80,93,167,198],"retrospective":[81,111,121,129],"study.":[82],"The":[83],"efficacy":[84],"tolerability":[86],"(exenatide":[90],"twice":[91],"daily":[92],"once":[94],"weekly,":[95],"dulaglutide,":[96],"liraglutide,":[97],"lixisenatide,":[98],"albiglutide)":[100],"were":[101,174,190],"compared":[102,169,217],"products":[105],"(23":[106],"prospective":[107,117,125,133,138],"studies":[108,118,126,226],"+":[109,119,127],"seven":[110],"studies),":[112,122,134],"dipeptidyl":[113],"peptidase-4":[114],"inhibitors":[115],"(11":[116],"three":[120],"sulfonylureas":[123],"(nine":[124],"one":[128],"study),":[130],"thiazolidinediones":[131],"(five":[132],"metformin":[136],"(two":[137],"studies).":[139],"are":[141,227,241],"effective":[142,177,243],"as":[143],"second-line":[145],"improving":[148],"glycemic":[149],"parameters":[150],"Reductions":[155],"glycated":[157],"hemoglobin":[158],"from":[159,224],"baseline":[160],"tended":[163],"be":[165],"greater":[166],"similar":[168],"therapy.":[172],"consistently":[175],"more":[176],"reducing":[179],"body":[180],"weight":[181],"than":[182],"most":[183],"oral":[184,219],"drugs":[186,247],"associated":[191],"lower":[193],"hypoglycemia":[194],"risk":[195,203],"versus":[196],"sulfonylureas.":[199],"improved":[201],"cardiovascular":[202,211],"factors,":[204],"preliminary":[206],"data":[207],"suggest":[208],"they":[209],"improve":[210],"outcomes":[212],"T2D":[216],"drugs.":[221],"However,":[222],"results":[223],"ongoing":[225],"awaited":[228],"confirm":[230],"these":[231],"early":[232],"findings.":[233],"CONCLUSION:":[234],"This":[235],"systematic":[236],"review":[237],"found":[238],"that":[239],"an":[242],"class":[244]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":10},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":19},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-03T10:50:19.383937","created_date":"2017-04-14T00:00:00"}